Work

The impact of PTEN deletion, TMPRSS2 : ERG fusion, and androgen receptor variant 7 (AR-V7) on resistance to novel hormone therapies (NHTs) in castrate-resistant prostate cancer.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e17036

Authors: Ksenia Kudriavtseva, Daria Yakimova, Alexander Rusinov, Evgeny Barykin, Mikhail Nikitin, Kirill Shaposhnikov, Vladimir Kushnarev, Nikita Kotlov, Alexander Bagaev, Andrey Kravets

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410809240

FWCI:

Cites:

Cited by:

Related to: 10